CAH February 2026 Options Begin Trading

Cardinal Health (CAH) is trading at $207.70 and the article outlines two option strategies: selling a $205 put (bid $5.20) which would set an effective purchase basis of $199.80 and is ~1% out‑of‑the‑money with a 58% chance to expire worthless, representing a 2.54% cash return (21.04% annualized). Alternatively, buying the stock and selling a $210 call (bid $5.90) would cap upside at $210 but deliver a 3.95% total return if called at Feb 2026 and a 2.84% premium boost (23.56% annualized) with a 51% chance the call expires worthless; implied volatility is ~30% vs. a 12‑month realized volatility of 26%.

Analysis

Market structure: Short-dated and LEAP-like option income trades around CAH benefit yield-seeking retail and income-focused funds (collecting ~2.5–2.8% premium to Feb 2026 for ~1% OTM strikes), while pure upside holders are hurt by capped gains. The implied vol (≈30%) sits ~4ppt above realized TTM vol (26%), signalling modest demand for protection/ income but not panic; flows into puts/calls at these strikes will modestly compress effective float and add temporary gamma to intraday trading. Cross-asset: this is equity-specific — limited bond/FX impact — but a broad roll-up of covered-call selling would rotate yield-hungry cash from fixed income into equity carry strategies, pressuring IG bond inflows if scaled to large funds.

Risk assessment: Tail risks include company-specific shocks (major reimbursement hit, litigation, or distribution disruption) that could cut CAH >15–25% and spike IV well above 50%, creating large assignment losses for put-sellers. Immediate (days) risk is theta/assignment and event risk; short-term (weeks–months) risk centers on earnings/analyst revisions; long-term (years) depends on secular healthcare distribution margins and concentration with two large peers. Hidden dependencies: liquidity in the Feb 2026 chain, early-assignment risk ahead of dividend-like events, and correlation shifts with peers (MCK, ABC) can materially change expected returns; catalysts include next earnings, pharmacy reimbursement rules, and macro recession signals.

Trade implications: For buy-and-hold investors comfortable with owning CAH, selling the Feb-2026 $205 put (collect $5.20 for effective $199.80) is attractive sized only if you are willing to own at that price — position size 1–3% NAV and cap downside with a $195 long put to form a $205/$195 bull put spread to limit max loss to ~$10 minus net credit. Alternatively, buy CAH at $207.70 and sell the Feb-2026 $210 call (collect $5.90) to generate a 3.95% gross return to call away (annualized ~23.6%); size as replacement for low-yield bond exposure up to 2% NAV. If directional conviction is low, implement a short-vol carry: sell put spreads rather than naked puts to control tail risk and close/roll if IV >45% or CAH < $185.

Contrarian angles: The market is underestimating tail risk — the 51–58% odds of options expiring worthless implicitly assume steady fundamentals; a single negative reimbursement or supply disruption would make these premiums look cheap. Conversely, if realized vol reverts to ~20–22% and fundamentals hold, these income trades will be underpriced and profitable; use small, actively managed allocations rather than buy-and-hold naked exposure to capture asymmetry. Historical parallel: income-selling in low-vol regimes (2017–2019) performed until a regime shock; plan for controlled exposure and predefined stop-loss or spread protection.

Key Decisions for Investors

• Establish a sell-to-open position: CAH Feb-2026 $205 put for $5.20 (effective buy price $199.80) sized to cover 1–3% of portfolio NAV only if willing to own CAH at $199.80; simultaneously buy the $195 put to create a $205/$195 bull put spread to cap downside and limit max loss to ~$10 minus net credit.
• Buy-and-write: Acquire CAH at market ($207.70) and sell the Feb-2026 $210 call for $5.90 to collect a 3.95% return to call date (cap upside above $210); limit position to 0.5–2% NAV and close if CAH >$220 or IV rises >45%.
• If seeking pure option carry with defined risk, sell the $205/$195 put spread instead of naked puts; roll or unwind if CAH trades below $185 or implied vol spikes above 45% (trigger to buy protection or cut position).
• Relative-value pair: Small-sized long CAH vs short ABC or MCK (1:1 by dollar exposure) for 3–6 months to extract idiosyncratic repricing; size modestly (≤1% NAV) and exit if spread widens >8% or CAH fundamentals deteriorate (earnings miss >5% EPS).